Article
ABCC8-related maturity-onset diabetes of the young: switching from insulin to sulphonylurea therapy: how long do we need for a good metabolic control?
Journal of pediatric endocrinology & metabolism : JPEM - 27 Jun 2023
Evin Ferda, Işık Esra, Onay Hüseyin, Özen Samim, Darcan Şükran, Gökşen Damla
Abstract excerpt
OBJECTIVES: Activating variants of the ABCC8 gene cause neonatal diabetes or maturity-onset diabetes of the young (MODY). We report three cases of MODY type 12 caused by variants in the ABCC8 encoding sulphonylurea receptor 1, and the experience of switching from insulin therapy to sulphonylurea therapy. CASE PRESENTATIONS: We describe a 12.5-year-old girl with permanent neonatal diabetes mellitus, and two...
Topics
Join the communities discussing this publication.
